Vancouver, BC, May 29, 2019--Virogin Biotech announced that it has recently signed an agreement with China National Biotec Group (CNBG) to create a Joint Venture that will focus on the research & development, clinical development, and commercialization of oncolytic virotherapies. The new company will be based at the Precision Medicine Industrial Park located in Nanxiang, Shanghai.
|